Doha – December 3, 2025: Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have published a study demonstrating the use of an advanced nanoparticle-based tool for analyzing human proteins in order to discover both their function and potential drug targets for treating genetic diseases. The research tool, provided by US biotech firm Seer, Inc., is a pioneer in the field of proteomics – the study of human proteins. Researchers believe that understanding the role of proteins in a host of human diseases holds the potential to enable the creation of a new generation of protein-targeting therapies, but analyzing the nature of proteins rem
